Growth Factors (Blood and Tissue) Market Size By Application, Industry Analysis Report, Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
52804 | Date :
Jan, 2023 | Pages :
192 | Region : Global |
Publisher : RI
Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.
The Global Growth Factors (Blood and Tissue) Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Growth Factors (Blood and Tissue) Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors
In Market segmentation by applications :
Hospital
Research lab
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Growth Factors (Blood and Tissue) Market for the forecast period 2023-2030?
• What are the driving forces in the Growth Factors (Blood and Tissue) Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Growth Factors (Blood and Tissue) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Growth Factors (Blood and Tissue) Market Size Growth Rate by Type (2020-2030)
1.3.2 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
1.3.3 Tissue Growth Factors
1.4 Market Segment by Application
1.4.1 Global Growth Factors (Blood and Tissue) Market Share by Application (2020-2030)
1.4.2 Hospital
1.4.3 Research lab
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Growth Factors (Blood and Tissue) Market Size
2.1.1 Global Growth Factors (Blood and Tissue) Revenue 2015-2030
2.1.2 Global Growth Factors (Blood and Tissue) Sales 2015-2030
2.2 Growth Factors (Blood and Tissue) Growth Rate by Regions
2.2.1 Global Growth Factors (Blood and Tissue) Sales by Regions 2015-2020
2.2.2 Global Growth Factors (Blood and Tissue) Revenue by Regions 2015-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Growth Factors (Blood and Tissue) Sales by Manufacturers
3.1.1 Growth Factors (Blood and Tissue) Sales by Manufacturers 2015-2020
3.1.2 Growth Factors (Blood and Tissue) Sales Market Share by Manufacturers 2015-2020
3.2 Revenue by Manufacturers
3.2.1 Growth Factors (Blood and Tissue) Revenue by Manufacturers (2018-2022)
3.2.2 Growth Factors (Blood and Tissue) Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Growth Factors (Blood and Tissue) Market Concentration Ratio (CR5 and HHI)
3.3 Growth Factors (Blood and Tissue) Price by Manufacturers
3.4 Key Manufacturers Growth Factors (Blood and Tissue) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Growth Factors (Blood and Tissue) Market
3.6 Key Manufacturers Growth Factors (Blood and Tissue) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Sales and Revenue (2018-2022)
4.1.2 Tissue Growth Factors Sales and Revenue (2018-2022)
4.2 Global Growth Factors (Blood and Tissue) Sales Market Share by Type
4.3 Global Growth Factors (Blood and Tissue) Revenue Market Share by Type
4.4 Growth Factors (Blood and Tissue) Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Growth Factors (Blood and Tissue) Sales by Application
6 United States
6.1 United States Growth Factors (Blood and Tissue) Breakdown Data by Company
6.2 United States Growth Factors (Blood and Tissue) Breakdown Data by Type
6.3 United States Growth Factors (Blood and Tissue) Breakdown Data by Application
7 European Union
7.1 European Union Growth Factors (Blood and Tissue) Breakdown Data by Company
7.2 European Union Growth Factors (Blood and Tissue) Breakdown Data by Type
7.3 European Union Growth Factors (Blood and Tissue) Breakdown Data by Application
8 China
8.1 China Growth Factors (Blood and Tissue) Breakdown Data by Company
8.2 China Growth Factors (Blood and Tissue) Breakdown Data by Type
8.3 China Growth Factors (Blood and Tissue) Breakdown Data by Application
9 Rest of World
9.1 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Company
9.2 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Type
9.3 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Application
9.4 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Countries
9.4.1 Rest of World Growth Factors (Blood and Tissue) Sales by Countries
9.4.2 Rest of World Growth Factors (Blood and Tissue) Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Amgen, Inc. (USA)
10.1.1 Amgen, Inc. (USA) Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.1.4 Growth Factors (Blood and Tissue) Product Introduction
10.1.5 Amgen, Inc. (USA) Recent Development
10.2 Bayer HealthCare Pharmaceuticals, Inc. (USA)
10.2.1 Bayer HealthCare Pharmaceuticals, Inc. (USA) Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.2.4 Growth Factors (Blood and Tissue) Product Introduction
10.2.5 Bayer HealthCare Pharmaceuticals, Inc. (USA) Recent Development
10.3 Biocon Ltd. (India)
10.3.1 Biocon Ltd. (India) Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.3.4 Growth Factors (Blood and Tissue) Product Introduction
10.3.5 Biocon Ltd. (India) Recent Development
10.4 Biogen, Inc. (USA)
10.4.1 Biogen, Inc. (USA) Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.4.4 Growth Factors (Blood and Tissue) Product Introduction
10.4.5 Biogen, Inc. (USA) Recent Development
10.5 BioMimetic Therapeutics LLC (USA)
10.5.1 BioMimetic Therapeutics LLC (USA) Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.5.4 Growth Factors (Blood and Tissue) Product Introduction
10.5.5 BioMimetic Therapeutics LLC (USA) Recent Development
10.6 Biopharm GmbH (Germany)
10.6.1 Biopharm GmbH (Germany) Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.6.4 Growth Factors (Blood and Tissue) Product Introduction
10.6.5 Biopharm GmbH (Germany) Recent Development
10.7 Bolder BioTechnology, Inc. (USA)
10.7.1 Bolder BioTechnology, Inc. (USA) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.7.4 Growth Factors (Blood and Tissue) Product Introduction
10.7.5 Bolder BioTechnology, Inc. (USA) Recent Development
10.8 F. Hoffmann-La Roche AG (Switzerland)
10.8.1 F. Hoffmann-La Roche AG (Switzerland) Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.8.4 Growth Factors (Blood and Tissue) Product Introduction
10.8.5 F. Hoffmann-La Roche AG (Switzerland) Recent Development
10.9 Chugai Pharmaceutical Co. Ltd. (Japan)
10.9.1 Chugai Pharmaceutical Co. Ltd. (Japan) Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.9.4 Growth Factors (Blood and Tissue) Product Introduction
10.9.5 Chugai Pharmaceutical Co. Ltd. (Japan) Recent Development
10.10 Genentech, Inc. (USA)
10.10.1 Genentech, Inc. (USA) Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
10.10.4 Growth Factors (Blood and Tissue) Product Introduction
10.10.5 Genentech, Inc. (USA) Recent Development
10.11 FibroGen, Inc. (USA)
10.12 Johnson & Johnson (USA)
10.13 Janssen Biotech, Inc. (USA)
10.14 Lonza Group (Switzerland)
10.15 Merck Serono (Germany)
10.16 PeproTech, Inc. (USA)
10.17 Reliance GeneMedix Plc (UK)
10.18 Sangamo Therapeutics, Inc. (USA)
10.19 Sanofi (France)
10.20 Scil Proteins GmbH (Germany)
10.21 Teva Pharmaceutical Industries Ltd. (Israel)
10.22 Wockhardt Ltd. (India)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Growth Factors (Blood and Tissue) Sales Channels
11.2.2 Growth Factors (Blood and Tissue) Distributors
11.3 Growth Factors (Blood and Tissue) Customers
12 Market Forecast
12.1 Global Growth Factors (Blood and Tissue) Sales and Revenue Forecast 2020-2030
12.2 Global Growth Factors (Blood and Tissue) Sales Forecast by Type
12.3 Global Growth Factors (Blood and Tissue) Sales Forecast by Application
12.4 Growth Factors (Blood and Tissue) Forecast by Regions
12.4.1 Global Growth Factors (Blood and Tissue) Sales Forecast by Regions 2020-2030
12.4.2 Global Growth Factors (Blood and Tissue) Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
